World’s Smallest & Lightest Artificial Heart Assist Device (LVAD)
Cardiac Megatrends
Key Benefits of the World’s Smallest & Lightest Artificial Heart Assist Device

Small-sized and lightweight compared to dominant US-made devices. The diameter is reduced by 40%, and the weight is reduced by 50%.

Implantation surgery is less invasive.

Low power consumption of up to 33 hours, with long endurance and a 50% reduction in the weight of peripherals.

Implantation surgery is less invasive.

Low power consumption of up to 33 hours with long endurance and 50% reduction in the weight of peripherals.

Fewer Infections with extra long durability Both percutaneous cable infection and severe infection have been reported as 0 case in clinical trial.

Better hemocompatibility with faster recovery of patients compared to similar LVADs.

Fewer Infections with extra long durability Both percutaneous cable infection and severe infection have been reported as 0 case in clinical trial.

Better hemocompatibility with faster recovery of patients compared to similar LVADs.

Related Study
Can a next-gen heart pump change the game for patients
with end-stage heart failure?

A new multi-center study explores the Corheart 6, an implantable left ventricular assist system, and its impact on survival, heart function, and safety over six months. With zero device failures, significant improvements in heart performance, and a 92.3% survival rate, this study reveals promising results for a growing population with limited treatment options.

Request access now to view the full study and explore the data behind this breakthrough.

LVAD-Related Trainings for Doctors in Indonesia
See photos of LVAD-related trainings for doctors in Indonesia, marking an unprecedented step forward in Indonesia’s heart care development and promoting a glocal exchange of medical knowledge and surgical expertise.
Press Releases

Indonesia Converges Advanced Medtech, AI, Medical Cloud and Regional Specialists on a Unified

Indonesia.md, the Indonesia-focused division of Borderless Healthcare Group, announced a major step...

Singapore-Led Medtech Initiative Brings Breakthrough Artificial Heart Assist Device Technology

Millions of heart-failure patients in Indonesia may soon gain access to a new Chinese-developed...

Borderless Healthcare Group Introduces Global Artificial Heart Solutions to Indonesia

Hospitals and clinics in Indonesia will soon be supported by Indonesia’s first medical...
Looking for Advance LVAD Solutions?
Let us know how we can help you whether you are a healthcare consumer looking for heart longevity, artificial heart assist implant device solutions, post-surgery care support.
Are you a patient interested to register for the LVAD program in Indonesia?
Are you a hospital in Indonesia interested in LVAD support?
⁠⁠⁠⁠Sign Up Now
Fill out the form below if you are seeking for artificial heart assist device implant evaluation for end-stage heart failure patients.
Connect with us on
Indonesia.md is a subsidiary of Borderless Healthcare Group. All rights reserved. Copyright 2026.